How Is Pharma Spending Tax Savings? Not On Drug Pricing, Sen. Booker Says

As pharma invests its bounty from last year's tax reform in stock buybacks, capital improvements and other investments, Sen. Cory Booker issues a report suggesting companies should lower drug prices instead, but does not offer recommendations for how that might be done.